HA
VCYT icon

Huntleigh Advisors’s Veracyte VCYT Stock Holding History

Huntleigh Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
25,918
+1,143
+5% +$47.9K 0.21% 103
2026
Q1 		$798K Buy
24,775
+779
+3% +$28.8K 0.14% 140
2025
Q4 		$1.01M Buy
23,996
+1,208
+5% +$48.7K 0.17% 123
2025
Q3 		$782K Buy
22,788
+979
+4% +$28.1K 0.13% 134
2025
Q2 		$590K Buy
21,809
+876
+4% +$25.4K 0.11% 139
2025
Q1 		$621K Buy
20,933
+2,070
+11% +$78.9K 0.1% 129
2024
Q4 		$747K Buy
+18,863
New +$714K 0.16% 108

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Huntleigh Advisors's VCYT Position: Q2 2026 in Review

Huntleigh Advisors increased its Veracyte (VCYT) stake by 4.6% in Q2 2026, buying an estimated $47.9K and bringing the position to 25,918 shares worth $1.52M. The position accounts for 0.21% of the portfolio, ranked #103.

Huntleigh Advisors first reported a position in VCYT in Q4 2024 and has held it in 7 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Huntleigh Advisors held 25,918 shares of Veracyte worth $1.52M as of Q2 2026.
  • Huntleigh Advisors bought 1,143 Veracyte shares in Q2 2026, an estimated $47.9K.
  • Veracyte made up 0.21% of Huntleigh Advisors's portfolio in Q2 2026, its #103 holding.
  • Huntleigh Advisors first reported a position in Veracyte in Q4 2024 and has held it in 7 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.